All about RAVN

The annual report for Resistance against Antivirals in Norway (RAVN) presents Norwegian data about antiviral resistance and highlights topics linked to treatment of viral infections.

The annual report from Resistance against Antivirals in Norway (RAVN) presents Norwegian data about antiviral resistance and covers topics related to the treatment of viral infections.

In Norwegian Surveillance System for Antiviral Resistance (RAVN), resistance of influenza viruses, HIV, hepatitis B virus (HBV), hepatitis C virus (HCV), cytomegalovirus (CMV) and herpes simplex virus (HSV) are monitored.

The annual report from Resistance against Antivirals in Norway (RAVN) presents Norwegian data about antiviral resistance and covers topics related to the treatment of viral infections.

The annual report from Resistance against antivirals in Norway (RAVN) with national data about antiviral resistance, focusing on relevant topics related to treatment of viral infections.

The annual report from Resistance against Antivirals in Norway (RAVN) presents national surveillance data on antiviral resistance for a number of viruses.

The annual report from Resistance against Antivirals in Norway (RAVN) presents national surveillance data on antiviral resistance and focuses on topics related to treatment of viral infections.

This is the third report from Resistance against Antivirals in Norway (RAVN). The report includes antiviral medicine use and surveillance data about viral resistance for 2015.

The 2011-2012 report includes general information about the RAVN surveillance system as well as virus resistance in Norway during the period.

This is the second report from Resistance against Antivirals in Norway (RAVN) about the usage of antiviral medicines and surveillance data for viral resistance for the biannual period 2013–2014.